Royalty Pharma plc RPRX
CIK 0001802768
Form 4 transactions dated Nov 1, 2023 to Nov 9, 2026, as reported to the SEC.
Insider purchases & sales
- Purchased
- $0.00
- Sold
- $135.93M
Nov 1, 2023 – Oct 5, 2026
Available records · partial months are marked ·
| Date | Insider | Activity | Trade value (USD) | % of prior holding | |
|---|---|---|---|---|---|
| Oct 5, 2026 | Urist Marshall EVP, Research & Investments | Sale10b5-1 footnote | $235.59K 4,126 shares sold | 100.00% sold Direct holding | ▾ |
| Sep 28, 2026 | Urist Marshall EVP, Research & Investments | Sale10b5-1 footnote | $238.81K 4,126 shares sold | 50.00% sold Direct holding | ▾ |
| Sep 22, 2026 | Hite Christopher EVP & Chairman, Partnering | Sale10b5-1 footnote | $5.85M 100,000 shares sold | 27.00% sold LLC holding | ▾ |
| Aug 18, 2026 | Hite Christopher EVP & Chairman, Partnering | Sale10b5-1 footnote | $6.00M 100,000 shares sold | 21.26% sold LLC holding | ▾ |
| Aug 13, 2026 | Coyne Terrance P. EVP & CFO | Sale10b5-1 footnote | $645.55K 11,002 shares sold | 100.00% sold LLC holding | ▾ |
| Jul 1, 2026 | Urist Marshall EVP, Research & Investments | Sale10b5-1 footnote | $508.45K 9,099 shares sold | 100.00% sold Direct holding | ▾ |
| Jun 30, 2026 | Hite Christopher EVP & Chairman, Partnering | Sale10b5-1 footnote | $5.65M 100,000 shares sold | 17.88% sold LLC holding | ▾ |
| Jun 30, 2026 | Hite Christopher EVP & Chairman, Partnering | Sale10b5-1 footnote | $1.69M 30,000 shares sold | 42.86% sold Direct holding | ▾ |
| Jun 24, 2026 | Urist Marshall EVP, Research & Investments | Sale10b5-1 footnote | $502.07K 9,098 shares sold | 50.00% sold Direct holding | ▾ |
| Jun 23, 2026 | Hite Christopher EVP & Chairman, Partnering | Sale10b5-1 footnote | $8.16M 150,000 shares sold | 21.14% sold LLC holding | ▾ |
Showing 30 / 39 record groups in 2026. The complete set is available through the API.
Follow the people behind the trades.
Log in to look up the full history beyond 3 years, use advanced screening & filtering, download CSV, and reach other datasets through the Akkru API.
- Download CSV
- Earlier filings
- Advanced screening & filtering
- API & AI access
+ New accounts get free API credits to explore data beyond ownership filings.
For AI agents & developers
The initial HTML of this page carries its exact data as script#research-data (JSON): values, units, scope, preview limits and SEC sources. Read it directly, no script or API key needed; script#research-access says what needs an account. For the year shown, this page lists 30 of 39 purchase / sale groups and 27 of 27 other groups; the totals and the monthly series cover the whole window.
Without an account: the last 3 years, with the row caps stated on the page. A free account opens all history on file on these pages and the CSV of what a page shows. Rows beyond the caps and bulk retrieval go through the authenticated API / MCP / CLI.
MCP https://api.akkrudata.ai/mcp
akkru_insider_transactions
{"action":"list","ticker":"RPRX","transaction_code":["P","S"],"transaction_form_type":"4","page_size":20}Connect to MCP with OAuth and follow the returned pagination. Credits and usage limits depend on the account.
- MCP endpoint
- https://api.akkrudata.ai/mcp
- API / MCP / CLI documentation
- /documents
- llms.txt
- /llms.txt
Sources, coverage & how to read this data
Figures are as reported to the SEC and merged with later amendments where Akkru could match them. Preview limits apply to what is listed, not to the totals, which come from the complete reported data. Nothing is zero-filled: a missing quarter or month is shown as missing.